Mbabane – Eswatini will extend its human papillomavirus (HPV) vaccination programme to include boys, the Ministry of Health announced, marking a significant step in the country’s efforts to combat cervical cancer for future generations of girls and women.
Health Minister Mduduzi Matsebula, represented at the event by Principal Secretary Khanyakwezwe Mabuza, said the move forms part of Phase 3 of the HPV vaccine rollout.
“This phase, which will be implemented within this year, will expand HPV vaccination to boys aged 9 to 14 years,” read Minister Matsebula’s remarks, delivered during the official presentation of three key strategic documents for the country’s Expanded Programme on Immunization (EPI). 
The three documents presented were the National Immunization Strategy, the Social and Behaviour Change Strategy, and the Effective Vaccine Management and Cold Chain Standard Operating Procedures.
The HPV vaccine protects against the human papillomavirus, which can cause genital warts and several types of cancer, particularly cervical cancer. It is most effective when administered before a person becomes sexually active.
World Health Organisation (WHO) Country Representative for Eswatini, Dr Susan Tembo, praised the government’s approach to immunization during the event.
“Allow me to particularly commend the Government of the Kingdom of Eswatini for its remarkable leadership and commitment to immunization. The decision to fully finance and procure 100% of the country’s vaccines is a powerful demonstration of national ownership and sustainability,” she said.
